Literature DB >> 19343354

Oncogenic role of microRNAs in brain tumors.

Jesse Chung-sean Pang1, Wai Kei Kwok, Zhongping Chen, Ho-Keung Ng.   

Abstract

MicroRNAs (miRNAs) are short non-protein-coding RNAs that function as key regulators of diverse biological processes through negative control on gene expression at the post-transcriptional level. Emerging evidence indicates that miRNAs play an important role in the development of human cancers, with their deregulation resulting in altered activity of downstream tumor suppressors, oncogenes and other signaling molecules. Recent years have seen considerable progress in miRNA research in brain tumors, particularly in glioblastomas and medulloblastomas, providing novel insights into the pathogenesis of these malignant lesions. Expression profiling has unveiled miRNA signatures that not only distinguish brain tumors from normal tissues, but can also differentiate histotypes or molecular subtypes with altered genetic pathways. Moreover, specific miRNA subsets may have potential diagnostic and prognostic values in some brain tumors. Several deregulated miRNAs uncovered in glioblastomas and medulloblastomas have their gene targets and the associated genetic pathways identified. This review summarizes recent findings of miRNA study in brain tumors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19343354     DOI: 10.1007/s00401-009-0525-0

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  46 in total

Review 1.  Defining larger roles for "tiny" RNA molecules: role of miRNAs in neurodegeneration research.

Authors:  Sowmya V Yelamanchili; Howard S Fox
Journal:  J Neuroimmune Pharmacol       Date:  2009-09-16       Impact factor: 4.147

Review 2.  MicroRNAs in brain tumors : a new diagnostic and therapeutic perspective?

Authors:  Richard Hummel; Jessica Maurer; Joerg Haier
Journal:  Mol Neurobiol       Date:  2011-07-08       Impact factor: 5.590

Review 3.  MicroRNAs in cancer: glioblastoma and glioblastoma cancer stem cells.

Authors:  Jeffrey V Brower; Paul A Clark; Will Lyon; John S Kuo
Journal:  Neurochem Int       Date:  2014-06-14       Impact factor: 3.921

4.  Expression and prognostic value of microRNAs in lower-grade glioma depends on IDH1/2 status.

Authors:  Wen Cheng; Xiufang Ren; Chuanbao Zhang; Sheng Han; Anhua Wu
Journal:  J Neurooncol       Date:  2017-01-16       Impact factor: 4.130

5.  Anti-miR21 oligonucleotide enhances chemosensitivity of T98G cell line to doxorubicin by inducing apoptosis.

Authors:  Laura Giunti; Martina da Ros; Serena Vinci; Stefania Gelmini; Anna Lisa Iorio; Anna Maria Buccoliero; Stefania Cardellicchio; Francesca Castiglione; Lorenzo Genitori; Maurizio de Martino; Sabrina Giglio; Maurizio Genuardi; Iacopo Sardi
Journal:  Am J Cancer Res       Date:  2014-12-15       Impact factor: 6.166

6.  Inhibitory effect of miR-184 on the potential of proliferation and invasion in human glioma and breast cancer cells in vitro.

Authors:  Ren Feng; Lei Dong
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

7.  MiR-218 sensitizes glioma cells to apoptosis and inhibits tumorigenicity by regulating ECOP-mediated suppression of NF-κB activity.

Authors:  Hongping Xia; Yukui Yan; Minghua Hu; Yaxian Wang; Yongsheng Wang; Yi Dai; Jianming Chen; Guangfu Di; Xiaobing Chen; Xiaochun Jiang
Journal:  Neuro Oncol       Date:  2012-12-14       Impact factor: 12.300

8.  MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN.

Authors:  Kai Zhou; Tingrong Zhang; YanDong Fan; Guojia Du; Pengfei Wu; Dangmurenjiafu Geng
Journal:  Tumour Biol       Date:  2016-07-27

9.  Micro-RNA-128 (miRNA-128) down-regulation in glioblastoma targets ARP5 (ANGPTL6), Bmi-1 and E2F-3a, key regulators of brain cell proliferation.

Authors:  J G Cui; Y Zhao; P Sethi; Y Y Li; A Mahta; F Culicchia; W J Lukiw
Journal:  J Neurooncol       Date:  2009-11-26       Impact factor: 4.130

10.  MiRNA expression profiling in human gliomas: upregulated miR-363 increases cell survival and proliferation.

Authors:  Alfredo Conti; Sara G Romeo; Annamaria Cama; Domenico La Torre; Valeria Barresi; Gaetana Pezzino; Chiara Tomasello; Salvatore Cardali; Filippo F Angileri; Francesca Polito; Guido Ferlazzo; Rosamaria Di Giorgio; Antonino Germanò; M'hammed Aguennouz
Journal:  Tumour Biol       Date:  2016-08-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.